LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 22.66 | 771.67 | 2595 | 2141 | 1.2118 | 1.2787 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 22.66 | 771.67 | 2369 | 2141 | 1.1062 | 1.1419 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.89 | 771.67 | 2896 | 2397 | 1.2078 | 1.2447 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 24.89 | 771.67 | 2655 | 2397 | 1.1073 | 1.1286 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 27.11 | 771.67 | 3214 | 2675 | 1.2014 | 1.2155 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 27.11 | 771.67 | 2926 | 2675 | 1.0938 | 1.1025 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 29.33 | 771.67 | 3591 | 2939 | 1.2217 | 1.2187 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 29.33 | 771.67 | 3209 | 2939 | 1.0917 | 1.0931 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 31.55 | 771.67 | 3889 | 3196 | 1.2165 | 1.2006 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 31.55 | 771.67 | 3507 | 3196 | 1.0971 | 1.0924 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 33.78 | 771.67 | 4174 | 3499 | 1.1927 | 1.1683 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 33.78 | 771.67 | 3820 | 3499 | 1.0915 | 1.0820 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 36.00 | 771.67 | 4631 | 3884 | 1.1921 | 1.1565 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 36.00 | 771.67 | 4226 | 3884 | 1.0878 | 1.0735 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 38.22 | 771.67 | 5110 | 4299 | 1.1885 | 1.1443 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 38.22 | 771.67 | 4568 | 4299 | 1.0624 | 1.0495 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 40.44 | 771.67 | 5549 | 4738 | 1.1711 | 1.1243 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 40.44 | 771.67 | 4889 | 4738 | 1.0318 | 1.0240 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 42.67 | 771.67 | 6076 | 5155 | 1.1785 | 1.1235 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 42.67 | 771.67 | 5390 | 5155 | 1.0454 | 1.0327 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 44.89 | 771.67 | 6464 | 5541 | 1.1665 | 1.1113 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 44.89 | 771.67 | 5694 | 5541 | 1.0275 | 1.0192 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.11 | 771.67 | 6979 | 5941 | 1.1746 | 1.1124 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 47.11 | 771.67 | 6179 | 5941 | 1.0400 | 1.0268 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 49.33 | 771.67 | 7579 | 6392 | 1.1856 | 1.1148 | MN20160304_L01 | I12 |